Professor Daniel Palmer

Molecular & Clinical Cancer Medicine

    Research

    Research Group Membership

    Research Grants

    Tissue bank - development of a process of tissue bio-banking and transfer of urological / hepatobilary specimens for academic unit

    THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST (UK)

    August 2014 - December 2019

    A prospective evaluation of a serological screening test for hepatocellular carcinoma; comparison with current standard of care

    LIVERPOOL HEALTH PARTNERS (UK)

    February 2013 - April 2016

    Liver research fund

    AINTREE UNIVERSITY HOSPITAL NHS FOUNDATION TRUST (CHARITY) (UK)

    April 2012 - March 2013

    To evaluate whether cardiopulmonary exercise testing (CPET) offers additional benefit above that of WHO performance status in predicting outcome of patients undergoing palliative chemotherapy for pancreatic cancer

    THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST (UK)

    January 2015 - December 2021

    FSF funding for Senior Trial Co-ordinator

    CLATTERBRIDGE CENTRE FOR ONCOLOGY

    November 2011 - May 2014

    Characterisation of dendritic cell function in the three-dimensional model of urothelial carcinoma in response to soluble CD40L based immunotherapy

    THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST (UK)

    May 2014 - December 2019

    A phase 1b study of pre-operative cisplatin and gemcitabine chemotherapy in patients with Borderline resectable Biliary tract Cancer: BBC-01 study

    NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH - NWCR (UK)

    September 2014 - December 2020

    Regulation of irinotecan anti-cancer pharmacology by Nrf2 – Implications for current use and potential for improved efficacy

    NORTH WEST CANCER RESEARCH FUND

    February 2014 - February 2016

    Stratification of adjuvant chemotherapeutic response to allow personalised choice of pyrimidine prodrug: based on levels of transporters and enzymes involved in initial metabolism

    CANCER RESEARCH UK (CRUK) (UK)

    November 2013 - April 2017

    ESPAC-5F Four arm, prospective, multicentre, randomised Phase II trial of immediate surgery compared with neoadjuvant chemotherapies and neoadjuvant chemoradiotherapy

    CANCER RESEARCH UK (CRUK) (UK)

    July 2013 - December 2019

    Chair of Oncology support

    CLATTERBRIDGE CANCER RESEARCH

    July 2011 - March 2017

    Applied Cancer Biology Group

    CLATTERBRIDGE CANCER RESEARCH

    February 2012 - July 2014

    Role of monocytes in the metastatic process: identification of novel molecular targets to fight pancreatic cancer

    PANCREATIC CANCER RESEARCH FUND (UK)

    July 2015 - June 2019